Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Detoxification pathways in the liver.

D M Grant1

  • 1Division of Clinical Pharmacology and Toxicology, Hospital for Sick Children, Toronto, Ontario, Canada.

Journal of Inherited Metabolic Disease
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

New solutions for combatting implant bacterial infection based on silver nano-dispersed and gallium incorporated phosphate bioactive glass sputtered films: A preliminary study.

Bioactive materials·2021
Same author

Analysis of bovine viral diarrhoea virus: Biobank and sequence database to support eradication in Scotland.

The Veterinary record·2017
Same author

Further investigations of the role of acetylation in sulphonamide hypersensitivity reactions.

Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals·2013
Same author

Transient serum exposure regimes to support dual differentiation of human mesenchymal stem cells.

Journal of tissue engineering and regenerative medicine·2012
Same author

A retrospective cohort study of the impact of biologic therapy initiation on medical resource use and costs in patients with moderate to severe psoriasis.

The British journal of dermatology·2010
Same author

The role of para-aminophenol in acetaminophen-induced methemoglobinemia in dogs and cats.

Journal of veterinary pharmacology and therapeutics·2010
Same journal

Beyond Upper Airway Involvement: Evidence of Intrinsic Lung Disease in a Mouse Model of Mucopolysaccharidosis I.

Journal of inherited metabolic disease·2026
Same journal

Immune Dysregulation in Branched Chain Organic Acidemias.

Journal of inherited metabolic disease·2026
Same journal

Long Term Follow-Up After Transplantation in Propionic Acidemia: A Retrospective French Pediatric and Adult Cohort Study.

Journal of inherited metabolic disease·2026
Same journal

Tri-Parametric Assessment of α-Galactosidase A Activity, lysoGb3 and X-Inactivation Aids Genotype-Phenotype Categorization of Fabry Disease Female Patients.

Journal of inherited metabolic disease·2026
Same journal

Mapping the Severity of Phenylalanine Hydroxylase Deficiency.

Journal of inherited metabolic disease·2026
Same journal

Gaucher Disease Treated With Lentiviral-Mediated Gene Therapy: First Case.

Journal of inherited metabolic disease·2026
See all related articles

The liver detoxifies harmful chemicals using enzymes that modify them for excretion. Variations in these enzymes, known as pharmacogenetic defects, can alter drug responses and toxicity.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Toxicology

Background:

  • The liver protects the body from toxic chemicals by metabolizing lipophilic compounds into water-soluble forms for excretion.
  • Xenobiotic biotransforming enzymes (Phase I and Phase II) in the liver handle diverse environmental chemicals due to their broad specificity, multiplicity, and inducibility.
  • Some chemicals can be converted into more toxic metabolites by these enzymes, and variations in enzyme activity can predispose individuals to toxicity.

Purpose of the Study:

  • To explain the liver's role in xenobiotic metabolism and chemical detoxification.
  • To highlight the significance of xenobiotic biotransforming enzymes in handling environmental chemical exposure.
  • To discuss the implications of pharmacogenetic defects in these enzymes for drug efficacy and toxicity.

Related Experiment Videos

Main Methods:

  • Review of the biochemical pathways involved in Phase I and Phase II metabolism.
  • Analysis of enzyme characteristics such as substrate specificity, isoenzyme multiplicity, and inducibility.
  • Examination of the impact of genetic variations on enzyme function and clinical outcomes.

Main Results:

  • Liver enzymes convert lipophiles into excretable metabolites, protecting the organism from toxic insults.
  • Enzyme systems are highly adaptable to a wide range of chemical structures encountered daily.
  • Genetic variations in xenobiotic biotransformation enzymes can lead to the formation of toxic metabolites and influence drug pharmacokinetics and pharmacodynamics.

Conclusions:

  • The liver's enzymatic machinery is crucial for detoxification and adaptation to environmental chemicals.
  • Variations in xenobiotic biotransformation enzymes, particularly pharmacogenetic defects, significantly impact individual responses to drugs and toxins.
  • Understanding these enzymatic variations is vital for predicting and managing drug efficacy and toxicity in diverse populations.